相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neogenin1 is a Sonic Hedgehog target in medulloblastoma and is necessary for cell cycle progression
Luis A. Milla et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
Edward C. Schwalbe et al.
ACTA NEUROPATHOLOGICA (2013)
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays
Volker Hovestadt et al.
ACTA NEUROPATHOLOGICA (2013)
Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development
P. A. Milligan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Processing Speed, Attention, and Working Memory After Treatment for Medulloblastoma: An International, Prospective, and Longitudinal Study
Shawna L. Palmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961
Roger J. Packer et al.
NEURO-ONCOLOGY (2013)
Histological variants of medulloblastoma are the most powerful clinical prognostic indicators
Maura Massimino et al.
PEDIATRIC BLOOD & CANCER (2013)
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma
Sarra L. Ryan et al.
ACTA NEUROPATHOLOGICA (2012)
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Paul A. Northcott et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children
Nicolas R. Smoll et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study
Regina I. Jakacki et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial
Birgitta Lannering et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J. Pugh et al.
NATURE (2012)
Novel mutations target distinct subgroups of medulloblastoma
Giles Robinson et al.
NATURE (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
NEURO-ONCOLOGY Understanding the molecular complexity of medulloblastoma
Roger J. Packer et al.
NATURE REVIEWS NEUROLOGY (2012)
The clinical implications of medulloblastoma subgroups
Paul A. Northcott et al.
NATURE REVIEWS NEUROLOGY (2012)
Medulloblastomics: the end of the beginning
Paul A. Northcott et al.
NATURE REVIEWS CANCER (2012)
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
David W. Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Genetic Landscape of the Childhood Cancer Medulloblastoma
D. Williams Parsons et al.
SCIENCE (2011)
Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease
David W. Ellison
ACTA NEUROPATHOLOGICA (2010)
Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis
Stefan Rutkowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Role of High-Dose Chemotherapy for Recurrent Medulloblastoma and Other CNS Primitive Neuroectodermal Tumors
Amar Gajjar et al.
PEDIATRIC BLOOD & CANCER (2010)
Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci
Stefan Pfister et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics
Sarah Fattet et al.
JOURNAL OF PATHOLOGY (2009)
Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial
Stephen J. Laughton et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Core neurocognitive functions in children treated for posterior fossa tumors
Donald J. Mabbott et al.
NEUROPSYCHOLOGY (2008)
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Marcel Kool et al.
PLOS ONE (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J. Packer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations
MC Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
β-catenin status predicts a favorable outcome in childhood medulloblastoma:: The United Kingdom Children's Cancer Study Group Brain Tumour Committee
DW Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastorna
RK Mulhern et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: A French Society of Pediatric Oncology study
V Oyharcabal-Bourden et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Medulloblastoma in the second decade of life: a specific group with respect to toxicity and management - A Canadian Pediatric Brain Tumor Consortium Study
U Tabori et al.
CANCER (2005)
Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood
DJ Mabbott et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone
S Rutkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Change in neurocognitive functioning after treatment with cranial radiation in childhood
BJ Spiegler et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas
CS McManamy et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology United Kingdom Children's Cancer Study Group PNET-3 study
RE Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Histopathologic grading of medulloblastomas - A pediatric oncology group study
CG Eberhart et al.
CANCER (2002)
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood:: Results of the German prospective randomized trial HIT '91
RD Kortmann et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
分享论文
